Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801

• Published in: Brain research bulletin 2021-09, Vol.174, p.141-152
• Main Authors: Sun, Zheng-yu, Gu, Li-Hong, Ma, Deng-lei, Wang, Ming-yang, Yang, Cui-cui, Zhang, Lan, Li, Xin-min, Zhang, Jie-wen, Li, Lin
• Format: Article
• Language: English
• Subjects: Animal model; Cuprizone; Fyn; MK-801; NMDA receptor; Schizophrenia; White matter lesion
• ISSN: 0361-9230; 1873-2747
• DOI: 10.1016/j.brainresbull.2021.06.007

•A novel mouse model of schizophrenia was established by MK-801 plus Cuprizone.•The novel model showed severe memory deficits, hyperactivity and anxiety disorder.•The novel model showed obvious demyelination and white matter damage.•The novel model displayed dysregulations in Fyn and NMDARs. Schizophrenia is a mental illness characterized by episodes of psychosis, apathy, social withdrawal, and cognitive impairment. White matter lesions and glutamatergic hypofunction are reported to be the key pathogeneses underlying the multiple clinical symptoms of schizophrenia. Cuprizone (CPZ) is a copper chelator that selectively injures oligodendrocytes, and MK-801 is an antagonist of the N-methyl d-aspartate (NMDA) receptor. To better mimic the psychosis and complicated pathogenesis of schizophrenia, a novel possible mouse model was established by the combination of CPZ and MK-801. After exposure to CPZ for 5 weeks, the mice received a daily intraperitoneal injection of MK-801 for 2-weeks. Behavioral changes in the mouse model were evaluated using Y-maze, object recognition, and open field tests. Pathological changes were observed by transmission electron microscopy, oil red O staining, immunohistochemistry, and western blotting. The results showed that the novel mouse model induced by CPZ plus MK-801 exhibited severe spatial and recognition memory deficits, hyperactivity, and anxiety disorder. Moreover, the mice showed obvious demyelination and white matter damage and decreased expression levels of myelin basic protein (MBP) and 2′,3′-cyclic nucleotide-3′-phosphodiesterase (CNPase) in the corpus callosum. Furthermore, the phosphorylation levels of Fyn and NMDA receptor 2B in the corpus callosum and NMDA receptor 1 in the cerebral cortex were noticeably decreased. Taken together, the novel mouse model induced by the combination of cuprizone and MK-801 showed comprehensive behavioral and neurobiological changes, which might make it a suitable animal model for schizophrenia.